Loading
Latest filing published 15 Feb 2024 for Sartorius Stedim Biotech, €400.0M. Read the official filing
No signal scores available.
Sartorius AG appears in our data through filings on Sartorius Stedim Biotech shares, published by AMF. Altogether 2 filings, all relating to 9 February 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 15 February 2024: a transaction of €400.0M, in Sartorius Stedim Biotech. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration